EUVIMEDObjevte EUVIMED
Crossref

Ginkgolide K delays the progression of osteoarthritis by regulating YAP to promote the formation of cartilage extracellular matrix

Ruizhou Liu iD, Zhendong Liu, Hui Chen, Shiping He, Shihan Wang, Jihang Dai, Xiaolei Li

Phytotherapy Research · 2023

DOI: 10.1002/ptr.7953 ↗

At a glance

Journal article in Phytotherapy Research, 2023. Written by Ruizhou Liu and 6 co-authors. Institution: Clinical Medical Collage of Yangzhou University, North Jiangsu People's Hospital, Yangzhou, China. Major MEDLINE topics: Osteoarthritis, Cartilage, Articular. Cited 5 times so far (Crossref); 52 references. Funded by: Medical Technology Reserve Talents of Northern Jiangsu Hospital, Postgraduate Research and Practice Innovation Program of Jiangsu Province (Yangzhou University, North Jiangsu People's Hospital, Yangzhou, China), China Postdoctoral Science Foundation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Osteoarthritis (OA) is a degenerative disease characterized by cartilage wear and degradation. Ginkgolide K (GK) is a natural compound extracted from Ginkgo biloba leaves and possesses anti‐inflammatory and anti‐apoptotic effects. We found that the biological characteristics of GK were highly consistent with those of OA medications. This study aimed to determine and verify the therapeutic effect of GK on OA and mechanism of its therapeutic effect. For the in vivo experiment, OA rats were regularly injected in the articular cavity with GK, and the curative effects were observed after 4 and 8 weeks. For the in vitro experiment, we treated OA chondrocytes with different concentrations of GK and then detected the related indices of OA. Through the in vivo and in vitro experiments, we found that GK could promote the production of major components of the cartilage extracellular matrix. Transcriptome sequencing revealed that GK may activate hypoxia‐inducible factor 1 alpha via the hypoxia signaling pathway, which, in turn, activates yes‐associated protein and inhibits apoptosis of OA chondrocytes. GK has a therapeutic effect on OA and, therefore, has the potential to be developed into a new drug for OA treatment.

Subjects

MeSH terms (MEDLINE)

OsteoarthritisCartilage, ArticularRatsAnimalsCartilageChondrocytesExtracellular MatrixLactonesGinkgolides

Author keywords

YAPapoptosisautophagyginkgolide Khypoxia-inducible factor 1osteoarthritis

Substances

ginkgolide KLactonesGinkgolides

Authors and institutions

  • Clinical Medical Collage of Yangzhou University, North Jiangsu People's Hospital, Yangzhou, China.
  • Dezhou People's Hospital, Dezhou, China.

ORCID profiles: Ruizhou Liu

Funding

  • Medical Technology Reserve Talents of Northern Jiangsu Hospital
  • Postgraduate Research and Practice Innovation Program of Jiangsu Province (Yangzhou University, North Jiangsu People's Hospital, Yangzhou, China)
  • China Postdoctoral Science Foundation
  • Jiangsu Funding Program for Excellent Postdoctoral Talent

Cite

APA

Liu, R., Liu, Z., Chen, H., He, S., Wang, S., Dai, J., & Li, X. (2023). Ginkgolide K delays the progression of osteoarthritis by regulating YAP to promote the formation of cartilage extracellular matrix. Phytotherapy Research. https://doi.org/10.1002/ptr.7953

Vancouver

Liu R, Liu Z, Chen H, He S, Wang S, Dai J, et al. Ginkgolide K delays the progression of osteoarthritis by regulating YAP to promote the formation of cartilage extracellular matrix. Phytotherapy Research. 2023. doi:10.1002/ptr.7953

BibTeX
@article{Liu2023,
  author = {Liu, Ruizhou and Liu, Zhendong and Chen, Hui and He, Shiping and Wang, Shihan and Dai, Jihang and Li, Xiaolei},
  title = {Ginkgolide K delays the progression of osteoarthritis by regulating YAP to promote the formation of cartilage extracellular matrix},
  journal = {Phytotherapy Research},
  year = {2023},
  doi = {10.1002/ptr.7953}
}
Start for free →